Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p175 has 84 genes in the original annotation. Currently, there are 67 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
3688	ITGB1	CD29 \| FNRB \| GPIIA \| MDF2 \| MSK12 \| VLA-BETA \| VLAB	integrin subunit beta 1	10p11.2
5728	PTEN	10q23del \| BZS \| CWS1 \| DEC \| GLM2 \| MHAM \| MMAC1 \| PTEN1 \| TEP1	phosphatase and tensin homolog	10q23.3
1147	CHUK	IKBKA \| IKK-alpha \| IKK1 \| IKKA \| NFKBIKA \| TCF16	conserved helix-loop-helix ubiquitous kinase	10q24-q25
7189	TRAF6	MGC:3310 \| RNF85	TNF receptor associated factor 6	11p12
5970	RELA	NFKB3 \| p65	v-rel avian reticuloendotheliosis viral oncogene homolog A	11q13
595	CCND1	BCL1 \| D11S287E \| PRAD1 \| U21B31	cyclin D1	11q13
330	BIRC3	AIP1 \| API2 \| CIAP2 \| HAIP1 \| HIAP1 \| MALT2 \| MIHC \| RNF49 \| c-IAP2	baculoviral IAP repeat containing 3	11q22
1027	CDKN1B	CDKN4 \| KIP1 \| MEN1B \| MEN4 \| P27KIP1	cyclin-dependent kinase inhibitor 1B	12p13.1-p12
1019	CDK4	CMM3 \| PSK-J3	cyclin-dependent kinase 4	12q14
5925	RB1	OSRC \| PPP1R130 \| RB \| p105-Rb \| pRb \| pp110	retinoblastoma 1	13q14.2
1282	COL4A1	BSVD \| RATOR	collagen type IV alpha 1	13q34
1284	COL4A2	ICH \| POREN2	collagen type IV alpha 2	13q34
4792	NFKBIA	IKBA \| MAD-3 \| NFKBI	NFKB inhibitor alpha	14q13
4149	MAX	bHLHd4	MYC associated factor X	14q23
207	AKT1	AKT \| CWS6 \| PKB \| PKB-ALPHA \| PRKBA \| RAC \| RAC-ALPHA	v-akt murine thymoma viral oncogene homolog 1	14q32.32
7187	TRAF3	CAP-1 \| CAP1 \| CD40bp \| CRAF1 \| IIAE5 \| LAP1	TNF receptor associated factor 3	14q32.32
8554	PIAS1	DDXBP1 \| GBP \| GU/RH-II \| ZMIZ3	protein inhibitor of activated STAT 1	15q
23533	PIK3R5	F730038I15Rik \| FOAP-2 \| P101-PI3K \| p101	phosphoinositide-3-kinase regulatory subunit 5	17p13.1
7157	TP53	BCC7 \| LFS1 \| P53 \| TRP53	tumor protein p53	17p13.1
9618	TRAF4	CART1 \| MLN62 \| RNF83	TNF receptor associated factor 4	17q11-q12
4843	NOS2	HEP-NOS \| INOS \| NOS \| NOS2A	nitric oxide synthase 2	17q11.2
3675	ITGA3	CD49C \| FRP-2 \| GAP-B3 \| GAPB3 \| ILNEB \| MSK18 \| VCA-2 \| VL3A \| VLA3a	integrin subunit alpha 3	17q21.33
284217	LAMA1	LAMA \| PTBHS \| S-LAM-alpha	laminin subunit alpha 1	18p11.3
9063	PIAS2	ARIP3 \| DIP \| MIZ \| MIZ1 \| PIASX \| PIASX-ALPHA \| PIASX-BETA \| SIZ2 \| ZMIZ4	protein inhibitor of activated STAT 2	18q21.1
596	BCL2	Bcl-2 \| PPP1R50	B-cell CLL/lymphoma 2	18q21.3
898	CCNE1	CCNE \| pCCNE1	cyclin E1	19q12
208	AKT2	HIHGHH \| PKBB \| PKBBETA \| PRKBB \| RAC-BETA	v-akt murine thymoma viral oncogene homolog 2	19q13.1-q13.2
5296	PIK3R2	MPPH \| MPPH1 \| P85B \| p85 \| p85-BETA	phosphoinositide-3-kinase regulatory subunit 2	19q13.2-q13.4
8503	PIK3R3	p55 \| p55-GAMMA \| p55PIK	phosphoinositide-3-kinase regulatory subunit 3	1p34.1
1870	E2F2	E2F-2	E2F transcription factor 2	1p36
5293	PIK3CD	APDS \| IMD14 \| P110DELTA \| PI3K \| p110D	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta	1p36.2
842	CASP9	APAF-3 \| APAF3 \| ICE-LAP6 \| MCH6 \| PPP1R56	caspase 9	1p36.21
10401	PIAS3	ZMIZ5	protein inhibitor of activated STAT 3	1q21
1163	CKS1B	CKS1 \| PNAS-16 \| PNAS-18 \| ckshs1	CDC28 protein kinase regulatory subunit 1B	1q21.2
6258	RXRG	NR2B3 \| RXRC	retinoid X receptor gamma	1q22-q23
5743	PTGS2	COX-2 \| COX2 \| GRIPGHS \| PGG/HS \| PGHS-2 \| PHS-2 \| hCox-2	prostaglandin-endoperoxide synthase 2	1q25.2-q25.3
7188	TRAF5	MGC:39780 \| RNF84	TNF receptor associated factor 5	1q32
10000	AKT3	MPPH \| MPPH2 \| PKB-GAMMA \| PKBG \| PRKBG \| RAC-PK-gamma \| RAC-gamma \| STK-2	v-akt murine thymoma viral oncogene homolog 3	1q44
598	BCL2L1	BCL-XL/S \| BCL2L \| BCLX \| Bcl-X \| PPP1R52	BCL2 like 1	20q11.21
3911	LAMA5	-	laminin subunit alpha 5	20q13.2-q13.3
3685	ITGAV	CD51 \| MSK8 \| VNRA \| VTNR	integrin subunit alpha V	2q31-q32
3655	ITGA6	CD49f \| ITGA6B \| VLA-6	integrin subunit alpha 6	2q31.1
2335	FN1	CIG \| ED-B \| FINC \| FN \| FNZ \| GFND \| GFND2 \| LETS \| MSF	fibronectin 1	2q34
1286	COL4A4	CA44	collagen type IV alpha 4	2q35-q37
2272	FHIT	AP3Aase \| FRA3B	fragile histidine triad	3p14.2
3913	LAMB2	LAMS \| NPHS5	laminin subunit beta 2	3p21
5915	RARB	HAP \| MCOPS12 \| NR1B2 \| RRB2	retinoic acid receptor beta	3p24.2
5291	PIK3CB	P110BETA \| PI3K \| PI3KBETA \| PIK3C1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta	3q22.3
5290	PIK3CA	CLOVE \| CWS5 \| MCAP \| MCM \| MCMTC \| PI3K \| p110-alpha	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	3q26.3
4790	NFKB1	CVID12 \| EBP-1 \| KBF1 \| NF-kB1 \| NF-kappa-B \| NF-kappaB \| NFKB-p105 \| NFKB-p50 \| NFkappaB \| p105 \| p50	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1	4q24
6502	SKP2	FBL1 \| FBXL1 \| FLB1 \| p45	S-phase kinase-associated protein 2, E3 ubiquitin protein ligase	5p13
3673	ITGA2	BR \| CD49B \| GPIa \| HPA-5 \| VLA-2 \| VLAA2	integrin subunit alpha 2	5q11.2
5295	PIK3R1	AGM7 \| GRB1 \| IMD36 \| p85 \| p85-ALPHA	phosphoinositide-3-kinase regulatory subunit 1	5q13.1
6257	RXRB	DAUDI6 \| H-2RIIBP \| NR2B2 \| RCoR-1	retinoid X receptor beta	6p21.3
1871	E2F3	E2F-3	E2F transcription factor 3	6p22
3910	LAMA4	CMD1JJ \| LAMA3 \| LAMA4*-1	laminin subunit alpha 4	6q21
3908	LAMA2	LAMM	laminin subunit alpha 2	6q22-q23
1021	CDK6	MCPH12 \| PLSTIRE	cyclin-dependent kinase 6	7q21-q22
3551	IKBKB	IKK-beta \| IKK2 \| IKKB \| IMD15 \| NFKBIKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta	8p11.2
9134	CCNE2	CYCE2	cyclin E2	8q22.1
4609	MYC	MRTL \| MYCC \| bHLHe39 \| c-Myc	v-myc avian myelocytomatosis viral oncogene homolog	8q24.21
5747	PTK2	FADK \| FAK \| FAK1 \| FRNK \| PPP1R71 \| p125FAK \| pp125FAK	protein tyrosine kinase 2	8q24.3
7185	TRAF1	EBI6 \| MGC:10353	TNF receptor associated factor 1	9q33-q34
7186	TRAF2	MGC:45012 \| TRAP \| TRAP3	TNF receptor associated factor 2	9q34
10319	LAMC3	OCCM	laminin subunit gamma 3	9q34.12
6256	RXRA	NR2B1	retinoid X receptor alpha	9q34.3
331	XIAP	API3 \| BIRC4 \| IAP-3 \| ILP1 \| MIHA \| XLP2 \| hIAP-3 \| hIAP3	X-linked inhibitor of apoptosis	Xq25